Kewaunee Scientific Corporation (KEQU)
- Previous Close
50.35 - Open
50.96 - Bid 51.46 x 100
- Ask 53.27 x 100
- Day's Range
50.58 - 52.39 - 52 Week Range
15.25 - 55.62 - Volume
13,356 - Avg. Volume
26,430 - Market Cap (intraday)
148.795M - Beta (5Y Monthly) 0.77
- PE Ratio (TTM)
8.21 - EPS (TTM)
6.38 - Earnings Date Aug 29, 2024 - Sep 2, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Sep 9, 2019
- 1y Target Est
--
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments: Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subsidiaries, and a national stocking distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.
www.kewaunee.com1,006
Full Time Employees
April 30
Fiscal Year Ends
Sector
Furnishings, Fixtures & Appliances
Industry
Recent News: KEQU
View MorePerformance Overview: KEQU
Trailing total returns as of 8/21/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: KEQU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: KEQU
View MoreValuation Measures
Market Cap
143.00M
Enterprise Value
130.74M
Trailing P/E
7.89
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.73
Price/Book (mrq)
2.61
Enterprise Value/Revenue
0.64
Enterprise Value/EBITDA
7.25
Financial Highlights
Profitability and Income Statement
Profit Margin
9.20%
Return on Assets (ttm)
6.95%
Return on Equity (ttm)
40.25%
Revenue (ttm)
203.76M
Net Income Avi to Common (ttm)
18.75M
Diluted EPS (ttm)
6.38
Balance Sheet and Cash Flow
Total Cash (mrq)
23.27M
Total Debt/Equity (mrq)
69.62%
Levered Free Cash Flow (ttm)
14.72M